Read + Share
Jimenez JE, Dai D, Xu G, Zhao R, et al. Lesion-Based Radiomics Signature in Pretherapy 18F-FDG PET Predicts Treatment
Response to Ibrutinib in Lymphoma. Clin Nucl Med 2022 Jan 11. pii: 00003072-900000000-95759.
PMID: 35020640
|
 |
|
Jimenez JE, Dai D, Xu G, Zhao R, et al. Lesion-Based Radiomics Signature in Pretherapy 18F-FDG PET Predicts Treatment
Response to Ibrutinib in Lymphoma. Clin Nucl Med 2022 Jan 11. pii: 00003072-900000000-95759.
PMID: 35020640
|
|
|
|